Parameters of glycemic control and their relationship with zinc concentrations in blood and with superoxide dismutase enzyme activity in type 2 diabetes patients;Parâmetros do controle glicêmico e sua relação com a zincemia e a atividade da enzima superóxido dismutase em pacientes diabéticos tipo 2

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 55, Issue 9, 2011, Pages 701-707

  de Sousa Lima, Vanessa Batista ^a   de Araújo Sampaio, Fabiane ^a   Bezerra, Daila Leite Chaves ^a   Neto, José Machado Moita ^a   Marreiro, Dilina do Nascimento ^a  

^a FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

Author keywords

Chronic hyperglycemia; Diabetes mellitus type 2; Superoxide dismutase; Zinc

Indexed keywords

EID: 84855841048     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302011000900006     Document Type: Article

References (43)

1. Ramakrishna V, Jailkhani R. Oxidative stress in non-insulin-dependent diabetes mellitus (NIDDM) patients. Acta Diabetol. 2008;45(1):41-6.
2. Mlinar B, Marc J, Janez A, Pfeifer M. Molecular mechanisms of insulin resistence and associated diseases. Clin Chim Acta. 2007;375(1-2):20-35.
3. Pan HZ, Zhang L, Guo M Y, Sui H, Li H, Wu WH, et al. The oxidative stress status in diabetes mellitus and diabetic nephropathy. Acta Diabetol. 2010;47(suppl 1):71S-6S.
4. Bravo A, Araújo S, Vargas ME, Mesa J, Souki A, Bermúdez V, et al. Actividad de la enzima antioxidante superóxido dismutasa y niveles de cobre y zinc em pacientes com diabetes mellitus tipo Arch Venezolanos de Farmacol Terap. 2007;26(1):1-7.
5. Agte VV, Nagmote RV, Tarwadi KV. Comparative in vitro uptake of zinc by erythrocytes of normal vs Type 2 diabetic individuals and the associated factors. Diabetes Nutr Metab. 2004;17(8):343-9.
6. Cimbaljevic B, Vasilijevic A, Cimbaljevic S, Buzadzic B, Korac A, Petrovic V, et al. Interrelationship of antioxidantive status, lipid peroxidation, and lipid profle in insulin-dependent and non-insulin-dependent diabetic patients. Can J Physiol Pharmacol. 2007;85(10):997-1003.
7. World Health Organization (WHO). Obesity: preventing and managing the global epidemic. Technical Report Series 2000, n. 894.
8. Anção MS, Cuppari L, Draibe AS, Sigulem D. Programa de apoio à nutrição Nutwin: versão 1.5. Departamento de Informática em Saúde SPDM 2002; Unifesp/EPM1 CD-ROM.
9. Tabela Brasileira de Composição de Alimentos/NEPA-Unicamp. NEPA-Unicamp, Campinas, São Paulo; 2006, p. 113.
10. Institute of Medicine/Food and Nutritional Board Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, cooper, iodine, iron, manganese, molybdenun, nickel, silicon, vanadium, and zinc. National Academy, Washington, DC; 2001, p. 650.
11. Rodriguez M P, Nazarino A, Demczylo V, Cid A. A simpler method for the determination of zinc human plasma levels by fame atomic absorption spectrophometry. At Spectrosc. 1989;10:68-70.
12. Whitehouse RC, Prasad AS, Rabbani PI, Cossack Z T. Zinc in plasma, neutrophils, lymphocytes, and erythrocytes as determined by fameless atomic absorption spectrophotometry. Clin Chem. 1982;28(3):475-80.
13. Van Assendelft, OW. The measurement of hemoglobin. In: Izak G, Lewis SM (eds.). Modern concepts in hematology. New York: Academic Press, 1972. p. 14-25.
14. Gibson RS. Assessment of chromium, copper and zinc status. In: Gibson RS (ed.). Principles of Nutritional Assessment. New York: Oxford University Press, 2005. p. 711-30.
15. Guthierie HA, Picciano M F. Micronutrient minerals. In: Guthierie HA (ed.). Human nutrition. New York: Mosby, 1994. p. 351-7.
16. American Diabetes Association/ADA. Standards of medical care in diabetes. Diabetes Care. 2010;33(suppl 1):11S-61S.
17. Matthews DR, Hosker J P, Rudenski AS, Naylor BA, Treacher D F, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-9.
18. Sociedade Brasileira de Cardiologia. IV Diretriz Brasileira sobre Dislipidemias e Prevenção da Aterosclerose. Arq Bras Cardiol. 2007;88(suppl 1):2S-19S.
19. Stefanović A, Kotur-Stevuljević J, Spasić S, Vekić J, Zeljković A, Spasojević-Kalimanovska V, et al. HDL-2 particles are associated with hyperglycaemia, lower PON1 activity and oxidative stress in type 2 diabetes mellitus patients. Clin Biochem. 2010;43(15):1230-5.
20. Rysz J, Błaszczak R, Banach M, Kedziora-Kornatowska K, Korna-towski T, Tanski W, et al. Evaluation of selected parameters of the antioxidative system in patients with type 2 diabetes in different periods of metabolic compensation. Arch Immunol Ther Exp. 2007;5(5):335-40.
21. Soliman GZ. Blood lipid peroxidation (superoxide dismutase, malondialdehyde, glutathione) levels in Egyptian type 2 diabetic patients. Singapore Med J. 2008;49(2):129-36.
22. Gross LJ, De-Azevedo JM, Silveiro PS, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005;28(1):164-76.
23. Jansen J, Karges W, Rink L. Zinc and diabetes-clinical links and molecular mechanisms. J Nutr Biochem. 2009;20(1):399-417.
24. Aguilar MV, Saavedra P, Arrieta FJ, Mateos CJ, González MJ, Meseguer I, et al. Plasma mineral content in type-2 diabetic patients and their association with the syndrome metabolic. Ann Nutr Me-tab. 2007;51(5):402-6.
25. Viktorínová A, Toserová E, Krizko M, Duracková Z. Altered metabolism of copper, zinc, and magnesium is associated with increased levels of glycated hemoglobin in patients with diabetes mellitus. Metabolism. 2009;58(10):1477-82.
26. Hess SY, Peerson JM, King JC, Brown KH. Use of serum zinc concentration as an indicator of population zinc status. Food Nutr Bull. 2007;28(suppl 3):403S-29S.
27. Lowe NM, Fekete K, Decsi T. Methods of assessment of zinc status in humans: a systematic review. Am J Clin Nutr. 2009;89(6):2040-51.
28. Marjani A. Plasma lipid peroxidation zinc and erythrocyte Cu-Zn superoxide dismutase enzyme activity in patients with type 2 diabetes mellitus in Gorgan City (South East of The Caspian Sea). Internet J Endocrinol. 2005;2(1):1-8.
29. Batista MN, Cuppari L, Pedrosa LFC, Almeida MG, Almeida JB, Medeiros AC, et al. Effect on end-stage disease and diabetes on zinc and copper status. Biol Trace Elem Res. 2006;112(1):1-12.
30. Kruse-Jarres JD, Rükgauer M. Trace elements in diabetes melli-tus. Peculiarities and clinical validity of determinations in blood cells. J Trace Elem Med Biol. 2000;14(1):21-7.
31. Marreiro DN, Martins MPSC, Sousa SSR, Ibiapina V, Torres S, Pi-res LV, et al. Urinary excretion of zinc and metabolic control of patients with diabetes Type 2. Biol Trace Elem Res. 2007;120(1-3): 42-50.
32. Mason AZ, Perico N, Moeller R, Thrippleton K, Potter T, Lloyd D. Metal donation and apo-metalloenzyme activation by stable isotopi-cally labeled metallothionein. Mar Environ Res. 2004;58(2-5):371-5.
33. Li X, Cai L, Feng W. Diabetes and metallothionein. Mini Rev Med Chem. 2007;7(7):761-8.
34. Likidlilid A, Patchanans N, Peerapatdit T, Sriratanasathavorn C. Li-pid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients. J Med Assoc Thai. 2010;93(6):682-93.
35. Aydin A, Orhan H, Sayal A, Ozata M, Sahin G, Isimer A. Oxidative stress and nitric oxide related parameters in type II diabetes melli-tus: effects of glycemic control. Clin Biochem. 2001;34(1):65-70.
36. Gumieniczek A, Hopkala H, Wojtowicz Z, Nieradko M. Differences in antioxidants status in skeletal muscle tissue in experimental diabetes. Clin Chim Acta. 2001;314(1-2):39-45.
37. Komosinska-Vassev K, Olczyk K, Olczyk P, Winsz-Szczotka K. Effects of metabolic control and vascular complications on indices of oxidative stress in type 2 diabetic patients. Diabetes Res Clin Pract. 2005;68(3):207-16.
38. Mahboob M, Rahman M F, Grover P. Serum lipid peroxidation and antioxidant enzyme levels in male and female diabetic patients. Singapore Med J. 2005;46(7):322-4.
39. Michiels C, Raes M, Toussaint O, Remacle J. Importance of Se-glutathione peroxidase, catalase and Cu/Zn SOD for cell survival against oxidative stress. Free Radic Biol Med. 1994;17(3):235-48.
40. Carmeli E, Coleman R, Berner YN. Activities of antioxidant scavenger enzymes (superoxide dismutase and glutathione peroxi-dase) in erythrocytes in adult women with and without type II diabetes. Experimental Diab Res. 2004;5(2):171-5.
41. Zbronska H, Grzeszczak W, Jendryczko A, Zbronski R, Kuzniewi-cz R. Activity of superoxide dismutase in erythrocytes and leukocytes and levels of zinc and copper in blood of patients with diabetes. Effect of diabetic treatment on examined parameters. Pol Arch Med Wewn. 1995;94(3):228-34.
42. Wittmann I, Nagy J. Are insulin resistance and atherosclerosis the consequences of oxidative stress? Diabetologia. 1996;39(8):1002-3.
43. Pavlović D, Kocić R, Kocić G, Jevtović T, Radenković S, Mikić, et al. Effect of four-week metformin treatment on plasma and erythrocyte antioxidative defense enzymes in newly diagnosed obese patients with type 2 diabetes. Diabetes Obes Metab. 2000;2(4):251-6.